申请人:Merck & Co., Inc.
公开号:US06241964B1
公开(公告)日:2001-06-05
The present invention is directed to radiolabeled neurokinin-1 receptor antagonists which are useful for the labeling and diagnostic imaging of neurokinin-1 receptors in mammals.
本发明涉及放射性标记的神经激肽-1受体拮抗剂,可用于哺乳动物神经激肽-1受体的标记和诊断成像。